Clinical Trials
24 trialsA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Center for International Blood and Marrow Transplant Research
inMMyCAR
Kelonia Therapeutics, Inc.
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
University of Florida
Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
University of Pittsburgh
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Memorial Sloan Kettering Cancer Center
MAPLE-UK
Hvivo
Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.
Case Comprehensive Cancer Center
First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies
Chimagen Biosciences, Ltd
Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OvaMa-PEDs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
Beijing Friendship Hospital
TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia
Shanghai Children's Medical Center
PIPPIN
Peter MacCallum Cancer Centre, Australia
Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia
Grupo Cooperativo de Hemopatías Malignas
Evaluation of Pressure Algometry in the Clinical Assessment of Acute Abdominal Pain in Children
University of Manitoba
LUPIAE
European Hematology Association - Lymphoma Group
MAPPING
Barts & The London NHS Trust
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
Chinese PLA General Hospital
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
GAINED
The Lymphoma Academic Research Organisation
TAVISTIM
University Hospital, Montpellier
KIR
Assistance Publique - Hôpitaux de Paris
HIV Indicator Diseases Survey Across Europe - UK Arm
Chelsea and Westminster NHS Foundation Trust